| abstract |
The present invention relates to a pharmaceutical composition comprising a controlled release PTH compound or a pharmaceutically acceptable salt, hydrate or solvate thereof for the treatment, control, delay or prophylaxis of which may be treated, controlled, delayed or prevented using PTH. A method of preventing a disorder wherein a pharmaceutical composition comprising a controlled release PTH compound is administered according to a dosage regimen wherein dosage adjustments in response to hypocalcemia or hypercalcemia are performed in increments of no more than 25%. |